SEC asks Biocon to submit safety, mortality data for Itolizumab
The company claims that approximately 2000 COVID-19 patients used the drug under the emergency use authorisation
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Prof Bejon Misra
Patient activist groups express relief over pause of Covishield trials in India
They call for more timely responses and accountability on part of both regulators and companies to ensure patient safety